MCATS for HIT Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
MCATS for HIT General Information
Description
Developer of a diagnostic test intended for identifying heparin-induced thrombocytopenia (HIT). The company uses measurement of cellular traction forces to detect pathogenic antibodies, enabling clinical laboratories to conduct accurate, rapid testing without the need for specialized equipment, reagents, or radioactive materials.
Contact Information
Corporate Office
- Atlanta, GA
- United States
Corporate Office
- Atlanta, GA
- United States
MCATS for HIT Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 15-Jul-2024 | Completed | Startup |
MCATS for HIT Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biolocity | Accelerator/Incubator |
MCATS for HIT FAQs
-
Where is MCATS for HIT headquartered?
MCATS for HIT is headquartered in Atlanta, GA.
-
What industry is MCATS for HIT in?
MCATS for HIT’s primary industry is Clinics/Outpatient Services.
-
Is MCATS for HIT a private or public company?
MCATS for HIT is a Private company.
-
What is MCATS for HIT’s current revenue?
The current revenue for MCATS for HIT is .
-
Who are MCATS for HIT’s investors?
Biolocity has invested in MCATS for HIT.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process